Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108

Article  PubMed  Google Scholar 

Sartorius K, Sartorius B, Aldous C, Govender PS, Madiba TE (2015) Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications. Cancer Epidemiol 39(3):284–290

Article  CAS  PubMed  Google Scholar 

de Lope CR, Tremosini S, Forner A, Reig M, Bruix J (2012) Management of HCC. J Hepatol 56(Suppl 1):S75-87

Article  PubMed  Google Scholar 

Aino H, Sumie S, Niizeki T, Kuromatsu R, Tajiri N, Nakano M, Satani M, Yamada S, Okamura S, Shimose S, Sumie H, Torimura T, Sata M (2014) Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis. Mol Clin Oncol 2(3):393–398

Article  PubMed  PubMed Central  Google Scholar 

Natsuizaka M, Omura T, Akaike T, Kuwata Y, Yamazaki K, Sato T, Karino Y, Toyota J, Suga T, Asaka M (2005) Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol 20(11):1781–1787

Article  PubMed  Google Scholar 

Kopp F, Mendell JT (2018) Functional classification and experimental dissection of long noncoding RNAs. Cell 172(3):393–407

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beermann J, Piccoli MT, Viereck J, Thum T (2016) Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev 96(4):1297–1325

Article  CAS  PubMed  Google Scholar 

Lavorgna G, Vago R, Sarmini M, Montorsi F, Salonia A, Bellone M (2016) Long non-coding RNAs as novel therapeutic targets in cancer. Pharmacol Res 110:131–138

Article  CAS  PubMed  Google Scholar 

Takahashi K, Yan I, Haga H, Patel T (2014) Long noncoding RNA in liver diseases. Hepatology 60(2):744–753

Article  CAS  PubMed  Google Scholar 

Zheng J, Xiong D, Sun X, Wang J, Hao M, Ding T, Xiao G, Wang X, Mao Y, Fu Y, Shen K, Wang J (2012) Signification of hypermethylated in cancer 1 (HIC1) as tumor suppressor gene in tumor progression. Cancer Microenviron 5(3):285–293

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao X, He M, Wan D, Ye Y, He Y, Han L, Guo M, Huang Y, Qin W, Wang MW, Chong W, Chen J, Zhang L, Yang N, Xu B, Wu M, Zuo L, Gu J (2003) The minimum LOH region defined on chromosome 17p13.3 in human hepatocellular carcinoma with gene content analysis. Cancer Lett 190(2):221–232

Zhang DY, Zou XJ, Cao CH, Zhang T, Lei L, Qi XL, Liu L, Wu DH (2018) Identification and functional characterization of long non-coding RNA MIR22HG as a tumor suppressor for hepatocellular carcinoma. Theranostics 8(14):3751–3765

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu PL, Tsai JR, Hwang JJ, Chou SH, Cheng YJ, Lin FY, Chen YL, Hung CY, Chen WC, Chen YH, Chong IW (2010) High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness. Am J Respir Cell Mol Biol 43(5):530–538

Article  CAS  PubMed  Google Scholar 

Wu Y, Zhou Y, Huan L, Xu L, Shen M, Huang S, Liang L (2019) LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR-10a-5p/NCOR2 axis in hepatocellular carcinoma cells. Cancer Sci 110(3):973–984

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi L, Zhang G, Zheng Z, Lu B, Ji L (2017) Andrographolide reduced VEGFA expression in hepatoma cancer cells by inactivating HIF-1α: the involvement of JNK and MTA1/HDCA. Chem Biol Interact 273:228–236

Article  CAS  PubMed  Google Scholar 

Ji L, Shen K, Jiang P, Morahan G, Wang Z (2011) Critical roles of cellular glutathione homeostasis and jnk activation in andrographolide-mediated apoptotic cell death in human hepatoma cells. Mol Carcinog 50(8):580–591

Article  CAS  PubMed  Google Scholar 

Pearngam P, Kumkate S, Okada S, Janvilisri T (2019) Andrographolide inhibits cholangiocarcinoma cell migration by down-regulation of claudin-1 via the p-38 signaling pathway. Front Pharmacol 10:827

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dai L, Wang G, Pan W (2017) Andrographolide inhibits proliferation and metastasis of SGC7901 gastric cancer cells. Biomed Res Int 2017:6242103

Article  PubMed  PubMed Central  Google Scholar 

Dai Y, Chen SR, Chai L, Zhao J, Wang Y, Wang Y (2019) Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide. Crit Rev Food Sci Nutr 59(sup1):S17-s29

Article  CAS  PubMed  Google Scholar 

Zhang L, Bao M, Liu B, Zhao H, Zhang Y, Ji X, Zhao N, Zhang C, He X, Yi J, Tan Y, Li L, Lu C (2020) Effect of andrographolide and its analogs on bacterial infection: a review. Pharmacology 105(3–4):123–134

Article  CAS  PubMed  Google Scholar 

Qu J, Liu Q, You G, Ye L, Jin Y, Kong L, Guo W, Xu Q, Sun Y (2022) Advances in ameliorating inflammatory diseases and cancers by andrographolide: pharmacokinetics, pharmacodynamics, and perspective. Med Res Rev 42(3):1147–1178

Article  CAS  PubMed  Google Scholar 

Chua LS (2014) Review on liver inflammation and antiinflammatory activity of Andrographis paniculata for hepatoprotection. Phytother Res 28(11):1589–1598

Article  PubMed  Google Scholar 

Zhou J, Zhang S, Ong CN, Shen HM (2006) Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells. Biochem Pharmacol 72(2):132–144

Article  CAS  PubMed  Google Scholar 

Xu J, Shao T, Song M, Xie Y, Zhou J, Yin J, Ding N, Zou H, Li Y, Zhang J (2020) MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer. Mol Cancer 19(1):51

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui Z, An X, Li J, Liu Q, Liu W (2018) LncRNA MIR22HG negatively regulates miR-141-3p to enhance DAPK1 expression and inhibits endometrial carcinoma cells proliferation. Biomed Pharmacother 104:223–228

Article  CAS  PubMed  Google Scholar 

Su W, Feng S, Chen X, Yang X, Mao R, Guo C, Wang Z, Thomas DG, Lin J, Reddy RM, Orringer MB, Chang AC, Yang Z, Beer DG, Chen G (2018) Silencing of long noncoding RNA MIR22HG triggers cell survival/death signaling via oncogenes YBX1, MET, and p21 in lung cancer. Cancer Res 78(12):3207–3219

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng X, Ye D, Hua K, Song H, Luo Q, Munankarmy A, Liu D, Zhou B, Zheng W, Zhou X, Ji C, Wang X, Yu Y, Fang L (2021) MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor. Cell Death Dis 12(9):810

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abdelmohsen K, Gorospe M (2010) Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip Rev RNA 1(2):214–229

Article  CAS  PubMed  Google Scholar 

Kim J, Abdelmohsen K, Yang X, De S, Grammatikakis I, Noh JH, Gorospe M (2016) LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR. Nucleic Acids Res 44(5):2378–2392

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abdelmohsen K, Lal A, Kim HH, Gorospe M (2007) Posttranscriptional orchestration of an anti-apoptotic program by HuR. Cell Cycle 6(11):1288–1292

Article  CAS  PubMed  Google Scholar 

Ishimaru D, Ramalingam S, Sengupta TK, Bandyopadhyay S, Dellis S, Tholanikunnel BG, Fernandes DJ, Spicer EK (2009) Regulation of Bcl-2 expression by HuR in HL60 leukemia cells and A431 carcinoma cells. Mol Cancer Res 7(8):1354–1366

Article  CAS  PubMed  Google Scholar 

Ayupova DA, Singh M, Leonard EC, Basile DP, Lee BS (2009) Expression of the RNA-stabilizing protein HuR in ischemia-reperfusion injury of rat kidney. Am J Physiol Renal Physiol 297(1):F95-f105

Article  CAS  PubMed  PubMed Central  Google Scholar 

Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305(5684):626–629

Article  CAS  PubMed  Google Scholar 

Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116(2):205–219

Article  CAS  PubMed  Google Scholar 

Slee EA, Adrain C, Martin SJ (1999) Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ 6(11):1067–1074

Article  CAS  PubMed  Google Scholar 

Kuribayashi K, Mayes PA, El-Deiry WS (2006) What are caspases 3 and 7 doing upstream of the mitochondria? Cancer Biol Ther 5(7):763–765